These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11343371)

  • 21. Bayesian cure rate models induced by frailty in survival analysis.
    de Souza D; Cancho VG; Rodrigues J; Balakrishnan N
    Stat Methods Med Res; 2017 Oct; 26(5):2011-2028. PubMed ID: 28656796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian cure rate frailty models with application to a root canal therapy study.
    Yin G
    Biometrics; 2005 Jun; 61(2):552-8. PubMed ID: 16011704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cure fraction estimation from the mixture cure models for grouped survival data.
    Yu B; Tiwari RC; Cronin KA; Feuer EJ
    Stat Med; 2004 Jun; 23(11):1733-47. PubMed ID: 15160405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new long-term survival model with dispersion induced by discrete frailty.
    Cancho VG; Macera MAC; Suzuki AK; Louzada F; Zavaleta KEC
    Lifetime Data Anal; 2020 Apr; 26(2):221-244. PubMed ID: 30968271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission.
    Singhal S; Henslee-Downey PJ; Powles R; Chiang KY; Godder K; Treleaven J; Kulkarni S; Van Rhee F; Sirohi B; Pinkerton CR; Meller S; Jovanovic B; Mehta J
    Bone Marrow Transplant; 2003 May; 31(10):889-95. PubMed ID: 12748665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A semiparametric cure model for interval-censored data.
    Lam KF; Wong KY; Zhou F
    Biom J; 2013 Sep; 55(5):771-88. PubMed ID: 23720128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compound Poisson frailty model with a gamma process prior for the baseline hazard: accounting for a cured fraction.
    Rahmati M; Rezanejad Asl P; Mikaeli J; Zeraati H; Rasekhi A
    J Appl Stat; 2022; 49(13):3377-3391. PubMed ID: 36213779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cure Weibull gamma-frailty survival model and its application to exploring the prognosis factors of neuroblastoma.
    Dokhi M; Ohtaki M; Hiyama E
    Hiroshima J Med Sci; 2009 Mar; 58(1):25-35. PubMed ID: 19400554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The exponentiated exponential mixture and non-mixture cure rate model in the presence of covariates.
    Mazucheli J; Coelho-Barros EA; Achcar JA
    Comput Methods Programs Biomed; 2013 Oct; 112(1):114-24. PubMed ID: 23932336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic frailty models based on compound birth-death processes.
    Putter H; van Houwelingen HC
    Biostatistics; 2015 Jul; 16(3):550-64. PubMed ID: 25681608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relaxed Poisson cure rate models.
    Rodrigues J; Cordeiro GM; Cancho VG; Balakrishnan N
    Biom J; 2016 Mar; 58(2):397-415. PubMed ID: 26686485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing for the presence of immune or cured individuals in censored survival data.
    Maller RA; Zhou S
    Biometrics; 1995 Dec; 51(4):1197-205. PubMed ID: 8589219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The exponential-Poisson model for recurrent event data: an application to a set of data on malaria in Brazil.
    Macera MA; Louzada F; Cancho VG; Fontes CJ
    Biom J; 2015 Mar; 57(2):201-14. PubMed ID: 25346061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gibbs sampling for long-term survival data with competing risks.
    Chao EC
    Biometrics; 1998 Mar; 54(1):350-66. PubMed ID: 9544528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A SAS macro for parametric and semiparametric mixture cure models.
    Corbière F; Joly P
    Comput Methods Programs Biomed; 2007 Feb; 85(2):173-80. PubMed ID: 17157948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Log-normal frailty models fitted as Poisson generalized linear mixed models.
    Hirsch K; Wienke A; Kuss O
    Comput Methods Programs Biomed; 2016 Dec; 137():167-175. PubMed ID: 28110722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mixture and nonmixture cure fraction models assuming discrete lifetimes: Application to a pelvic sarcoma dataset.
    de Oliveira RP; Menezes AFB; Mazucheli J; Achcar JA
    Biom J; 2019 Jul; 61(4):813-826. PubMed ID: 30762893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of intervention effects using recurrent event time data in the presence of event dependence and a cured fraction.
    Xu Y; Lam KF; Cheung YB
    Stat Med; 2014 Jun; 33(13):2263-74. PubMed ID: 24449504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression models for infant mortality data in Norwegian siblings, using a compound Poisson frailty distribution with random scale.
    Moger TA; Aalen OO
    Biostatistics; 2008 Jul; 9(3):577-91. PubMed ID: 18304994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.